| The A.I. Trend Has These 7 Stocks Set To Soar (ad) |
Making profits in the stock market depends on making your entry at the right time. The time is NOW to get into A.I. Artificial Intelligence is turning into one of the most popular trends this year, and it has only just begun.
(**By clicking the link you are subscribing to the The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
Go HERE to Reveal Which Stock These Are |
|
| The #1 Energy Passive Income Investment for 2023 (ad) |
It's not a stock, bond or private company... But this little-known alternative investment could hand you BIG MONTHLY INCOME from the oil and gas surge in 2023.
Click Here to Find Out More |
|
You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. - Amgen (NASDAQ:AMGN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $320.00 price target on the stock, up previously from $260.00. This represents a 19.8% upside from the current price of $267.10.
- Banco Santander-Chile (NYSE:BSAC) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $20.00 price target on the stock, down previously from $22.00. This represents a 11.7% upside from the current price of $17.90.
- Clorox (NYSE:CLX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $150.00 price target on the stock, up previously from $135.00. This represents a 21.0% upside from the current price of $123.95.
- Chevron (NYSE:CVX) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $182.00 price target on the stock, down previously from $184.00. This represents a 24.1% upside from the current price of $146.69.
- 8X8 (NASDAQ:EGHT) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. This represents a 48.0% upside from the current price of $3.04.
- Generac (NYSE:GNRC) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $135.00 price target on the stock, up previously from $130.00. This represents a 32.1% upside from the current price of $102.21.
- Methanex (NASDAQ:MEOH) (TSE:MX) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $45.00 price target on the stock, up previously from $40.00. This represents a 4.0% upside from the current price of $43.28.
- Oscar Health (NYSE:OSCR) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock, up previously from $8.00. This represents a 65.7% upside from the current price of $5.43.
- Roku (NASDAQ:ROKU) was upgraded by analysts at Pivotal Research from a "sell" rating to a "hold" rating. They now have a $75.00 price target on the stock, up previously from $58.00. This represents a 3.1% downside from the current price of $77.43.
- Silicon Motion Technology (NASDAQ:SIMO) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $75.00 price target on the stock, up previously from $60.00. This represents a 33.0% upside from the current price of $56.39.
- Trade Desk (NASDAQ:TTD) was upgraded by analysts at New Street Research from a "sell" rating to a "neutral" rating.The current price is $75.47.
- TTM Technologies (NASDAQ:TTMI) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $16.50 price target on the stock, up previously from $16.00. This represents a 20.4% upside from the current price of $13.70.
- View today's most recent analysts' upgrades at MarketBeat.com
| Wall Street Caliber A.I. for the "Little Guy" (ad) |
For years, Wall Street's been using A.I. to gain an edge. Now, a top tech company is "leveling the playing field." For over six years now, they've been developing a cutting edge A.I. algorithm that can predict future stock prices with astonishing accuracy.
Get the full story here |
|
- Alignment Healthcare (NASDAQ:ALHC) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $7.25 price target on the stock, down previously from $7.50. This represents a 11.5% upside from the current price of $6.50.
- Bristol-Myers Squibb (NYSE:BMY) was downgraded by analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating. They now have a $54.00 price target on the stock, down previously from $68.00. This represents a 5.9% upside from the current price of $50.98.
- Confluent (NASDAQ:CFLT) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $24.00 price target on the stock, down previously from $38.00. This represents a 49.8% upside from the current price of $16.02.
- Confluent (NASDAQ:CFLT) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $26.00 price target on the stock. This represents a 62.3% upside from the current price of $16.02.
- Community Healthcare Trust (NYSE:CHCT) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $32.00 price target on the stock, down previously from $36.00. This represents a 13.5% upside from the current price of $28.20.
- Estée Lauder Companies (NYSE:EL) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating. They now have a $115.00 price target on the stock, down previously from $210.00. This represents a 3.2% upside from the current price of $111.42.
- Estée Lauder Companies (NYSE:EL) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $115.00 price target on the stock, down previously from $195.00. This represents a 3.2% upside from the current price of $111.42.
- Eastman Chemical (NYSE:EMN) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $81.00 price target on the stock, down previously from $91.00. This represents a 7.4% upside from the current price of $75.39.
- Hess (NYSE:HES) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $166.00 price target on the stock, down previously from $189.00. This represents a 14.0% upside from the current price of $145.67.
- IQVIA (NYSE:IQV) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $202.00 price target on the stock, down previously from $248.00. This represents a 9.0% upside from the current price of $185.25.
- Moderna (NASDAQ:MRNA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating. They now have a $60.00 price target on the stock, down previously from $125.00. This represents a 14.2% downside from the current price of $69.90.
- MasTec (NYSE:MTZ) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.The current price is $45.87.
- Envista (NYSE:NVST) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00. This represents a 19.0% upside from the current price of $21.01.
- ONEOK (NYSE:OKE) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $68.00 price target on the stock. This represents a 4.3% upside from the current price of $65.18.
- Paycom Software (NYSE:PAYC) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $185.00 price target on the stock, down previously from $330.00. This represents a 25.4% upside from the current price of $147.54.
- Procore Technologies (NYSE:PCOR) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $49.75.
- Procore Technologies (NYSE:PCOR) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $55.00 price target on the stock, down previously from $90.00. This represents a 10.6% upside from the current price of $49.75.
- Peloton Interactive (NASDAQ:PTON) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $5.00 price target on the stock. This represents a 4.0% downside from the current price of $5.21.
- Qorvo (NASDAQ:QRVO) was downgraded by analysts at Summit Insights from a "buy" rating to a "hold" rating.The current price is $82.66.
- Sunrun (NASDAQ:RUN) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $12.00 price target on the stock, down previously from $17.00. This represents a 17.9% upside from the current price of $10.18.
- Sunrun (NASDAQ:RUN) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $12.00 price target on the stock. This represents a 17.9% upside from the current price of $10.18.
- Revolve Group (NYSE:RVLV) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $12.67.
- SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $69.53.
- SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $77.00 price target on the stock, down previously from $187.00. This represents a 10.7% upside from the current price of $69.53.
- SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $71.00 price target on the stock. This represents a 2.1% upside from the current price of $69.53.
- SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $70.00 price target on the stock, down previously from $120.00. This represents a 0.7% upside from the current price of $69.53.
- SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $68.00 price target on the stock, down previously from $111.00. This represents a 2.2% downside from the current price of $69.53.
- Spirit Realty Capital (NYSE:SRC) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $40.00 price target on the stock. This represents a 6.1% upside from the current price of $37.71.
- View today's most recent analysts' downgrades at MarketBeat.com
| Markets are All Over the Place! Here's the #1 Way to Play It (ad) |
|
- Amazon.com (NASDAQ:AMZN) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $160.00 price target on the stock. This represents a 16.7% upside from the current price of $137.13.
- Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Mizuho. They set a "neutral" rating and a $42.00 price target on the stock. This represents a 17.6% downside from the current price of $50.94.
- EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Mizuho. They set a "buy" rating and a $20.00 price target on the stock. This represents a 162.8% upside from the current price of $7.61.
- Immunocore (NASDAQ:IMCR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.The current price is $46.10.
- Immatics (NASDAQ:IMTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.The current price is $8.01.
- WK Kellogg (NYSE:KLG) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $11.00 price target on the stock. This represents a 11.0% upside from the current price of $9.91.
- MoonLake Immunotherapeutics (NASDAQ:MLTX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $74.00 price target on the stock. This represents a 54.6% upside from the current price of $47.86.
- Merus (NASDAQ:MRUS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $45.00 price target on the stock. This represents a 102.2% upside from the current price of $22.25.
- View today's most recent analysts' new coverage at MarketBeat.com
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
| Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | UPGRADE NOW |
|
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2023 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103 . United States. Today's Bonus Content: 6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company |
No comments:
Post a Comment